ATR

AptarGroup Inc
NYSEHEALTHCAREMEDICAL INSTRUMENTS & SUPPLIES

Key Statistics

Market Cap
$9.03B
P/E Ratio
34.42
EPS
$4.14
Beta
0.32
52W High
$148.63
52W Low
$110.56
50-Day MA
$126.80
200-Day MA
$127.43
Dividend Yield
1.33%
Profit Margin
6.70%
Forward P/E
23.75
PEG Ratio
3.16

About AptarGroup Inc

AptarGroup, Inc. offers a range of packaging, dispensing and sealing solutions primarily for the beauty, personal care, home care, prescription drug, consumer health care, injectables, and food and beverage markets. The company is headquartered in Crystal Lake, Illinois.

Official WebsiteUSAFY End: December

Fundamentals

Revenue (TTM)$3.99B
Gross Profit (TTM)$1.43B
EBITDA$801.39M
Operating Margin13.80%
Return on Equity9.79%
Return on Assets6.05%
Revenue/Share (TTM)$62.32
Book Value$41.23
Price-to-Book3.49
Price-to-Sales (TTM)2.26
EV/Revenue2.59
EV/EBITDA14.08
Quarterly Earnings Growth (YoY)-73.40%
Quarterly Revenue Growth (YoY)6.00%
Shares Outstanding$63.39M
Float$62.77M
% Insiders0.86%
% Institutions98.50%

Historical Volatility

HV 10-Day
39.69%
HV 20-Day
31.58%
HV 30-Day
28.10%
HV 60-Day
23.14%
HV Rank
80.6%

Volatility is currently expanding

Analyst Ratings

Consensus ($163.88 target)
2
Strong Buy
5
Buy
2
Hold

Latest News

AptarGroup, Inc. (ATR) Q3 2026 Earnings Call Transcript

AptarGroup, Inc. ( ATR ) Q3 2026 Earnings Call October 30, 2026 9:00 AM EDT Company Participants Marry Skafidas - Senior Vice President of Investor Relations & Communications Gael Touya - CEO, President & Director Vanessa Kanu - Executive VP & CFO Conference Call Participants Ghansham Panjabi - Robert W. Baird & Co. Incorporated, Research Division Paul Knight - KeyBanc Capital Markets Inc., Research Division Matthew Roberts - Raymond James & Associates, Inc., Research Division George Staphos - BofA Securities, Research Division Matthew Larew - William Blair & Company L.L.C.

Seeking Alpha10/30/2026Neutral
What AptarGroup (ATR) Said on Its Q3 Earnings Call

AptarGroup NYSE: ATR reported third-quarter 2026 sales growth across its three business segments, while adjusted profitability declined from the prior year as emergency medicine destocking and lower margins in Beauty and Closures weighed on results.

MarketBeat10/30/2026Positive

Turn research into an automated options-selling system

Tiblio connects your broker and runs your put-and-call-writing strategy for you — on ATR and any ticker you trade — then tracks every position and per-strategy win rate.

See how it works

More HEALTHCARE Stocks

Data last updated: 11/7/2026